United States  

Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

Business Insider Monday, 18 May 2020
Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)**

· *Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. *
· *Shares of the company surged 29% on Monday. *
· *The company is aiming to have the vaccine ready for emergency use in the fall.*
· *Watch Moderna trade live on Markets Insider.*
· *Read more...
1
shares
ShareTweetSavePostSend
 
Video Credit: WBZ CBS Boston - Published
News video: Moderna Reports Phase 1 Success In Coronavirus Vaccine Tests

Moderna Reports Phase 1 Success In Coronavirus Vaccine Tests 01:41

Moderna reported encouraging news about its potential coronavirus vaccine.

You Might Like


Related videos from verified sources

WBZ News Update For May 30 [Video]

WBZ News Update For May 30

Massachusetts coronavirus cases; Moderna enters second stage of coronavirus vaccine trial; Cool Sunday.

Credit: WBZ CBS Boston     Duration: 02:55Published
Cambridge Biotech Company Moderna Begins Second Stage Of Coronavirus Vaccine Study [Video]

Cambridge Biotech Company Moderna Begins Second Stage Of Coronavirus Vaccine Study

WBZ-TV's Ken MacLeod reports.

Credit: WBZ CBS Boston     Duration: 00:24Published
SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients [Video]

SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients

SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients

Credit: ABC 10 News | San Diego     Duration: 02:04Published

Related news from verified sources

Moderna skyrockets 39% after its early trial of a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

· *Moderna announced on Monday that all 45 patients in an early trial of its coronavirus vaccine candidate produced antibodies that could help protect them...
Business Insider

Moderna says Covid-19 vaccine boosted antibodies in early-stage trial

Worldwide hope for a Covid-19 vaccine got a boost Monday after Cambridge biotech Moderna Inc. reported that its candidate showed positive effects in an...
bizjournals


Tweets about this